When ZNF750 mutations and deletions were combined, the associations with late stage (P = 0.006), more lymph node metastasis (P = 0.000453), and poorer survival (P = 0.016) were highly significant (Fig. 1h and Table S3). Here, ZNF750 is linked to metastatic malignant neoplasm in the lymph nodes.